Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002

Amanda Langley; Nada K. Kakadadse; Stephen Swailes

doi:10.1080/09537320500357509

Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002

Amanda Langley, Nada K. Kakadadse, Stephen Swailes

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.

Original language	English
Pages (from-to)	519-534
Number of pages	16
Journal	Technology Analysis and Strategic Management
Volume	17
Issue number	4
DOIs	https://doi.org/10.1080/09537320500357509
Publication status	Published - Dec 2005
Externally published	Yes

Access to Document

10.1080/09537320500357509

Cite this

@article{9b407a379f574dd9bff4550597885b85,

title = "Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002",

abstract = "This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.",

author = "Amanda Langley and Kakadadse, {Nada K.} and Stephen Swailes",

year = "2005",

month = dec,

doi = "10.1080/09537320500357509",

language = "English",

volume = "17",

pages = "519--534",

journal = "Technology Analysis and Strategic Management",

issn = "0953-7325",

publisher = "Routledge",

number = "4",

}

TY - JOUR

T1 - Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002

AU - Langley, Amanda

AU - Kakadadse, Nada K.

AU - Swailes, Stephen

PY - 2005/12

Y1 - 2005/12

N2 - This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.

AB - This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.

UR - http://www.scopus.com/inward/record.url?scp=31344461855&partnerID=8YFLogxK

U2 - 10.1080/09537320500357509

DO - 10.1080/09537320500357509

M3 - Article

AN - SCOPUS:31344461855

VL - 17

SP - 519

EP - 534

JO - Technology Analysis and Strategic Management

JF - Technology Analysis and Strategic Management

SN - 0953-7325

IS - 4

ER -

Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002

Abstract

Access to Document

Other files and links

Fingerprint

Cite this